Neurology Alert (Vol. 34, No. 10) - June 1, 2015

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: June 2015

Valid through: June 2018

Target Audience

This activity is intended for the neurologist.

Subjects

  • REM Behavior Disorder — A Unique Window into the Mysteries of Neurodegenerative Disease
  • Linking Traumatic Brain Injury and Parkinson’s Disease: The Evidence Builds
  • Repetitive Transcranial Magnetic Stimulation for Treatment of Parkinson’s Disease
  • Non-Ischemic Forearm Exercise Testing for McArdle’s Disease
  • Cognitive Function in Creutzfeldt-Jakob Disease
  • Stroke Alert: Natriuretic Peptide Measurements May Help Diagnose Cardioembolic Stroke
  • Stroke Alert: Cryptogenic Stroke and Atrial Fibrillation

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credit(s)

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Alan Z. Segal, MD, Associate Professor of Clinical Neurology, Weill Cornell Medical College

Claire Henchcliffe, MD, Associate Professor of Neurology and Neuroscience, Weill Cornell Medical College

Douglas Labar, MD, PhD, Professor of Neurology, Weill Cornell Medical College

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Joseph E. Safdieh, MD, Associate Professor of Neurology, Weill Cornell Medical College

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media executive editor: Leslie G. Coplin

Managing editor: Jonathan Springston

Financial Disclosure

Author Claire Henchcliffe, MD, reports she is on the speakers bureau and advisory board for GE, Teva Pharmaceutical Industries, and UCB; advisory board for Allergan and USWorldmeds; receives grant/research support fromBiogen and Kaneka; and does CME program development and presentation for MedIQ.

Authors Matthew E. Fink, MD; Alan Z. Segal, MD; Douglas Labar, MD, PhD; Michael Rubin, MD; and Joseph Safdieh, MD report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew Fink, MD; peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2015, AHC Media. All rights reserved.